Inflammation and Immunity in Schizophrenia

Schizophrenia is a complex mental disease caused by a combination of serial alterations in genetic and environmental factors, including inflammation and immunity. Here is the latest research.

April 14, 2021
Open Access

HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.

Translational Psychiatry
Bettina KonteIna Giegling
April 13, 2021

The cannabinoid system and microglia in health and disease.

Samuel S DuffyGila Moalem-Taylor
April 12, 2021

Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum.

Schizophrenia Research
Robert FreedmanM Camille Hoffman
April 11, 2021

Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes.

Molecular Psychiatry
Mélanie DruartCorentin Le Magueresse
April 11, 2021

Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions.

Brain Research Bulletin
Luana M ManossoGislaine Z Réus
April 11, 2021

Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder.

Brain, Behavior, and Immunity
Liliana LaskarisVanessa Cropley
April 10, 2021
Open Access

Effects of maternal immune activation in porcine transcript isoforms of neuropeptide and receptor genes.

Journal of Integrative Neuroscience
Bruce R SoutheySandra L Rodriguez-Zas
April 5, 2021
Open Access

Spatial Learning Is Impaired in Male Pubertal Rats Following Neonatal Daily but Not Randomly Spaced Maternal Deprivation.

Frontiers in Cell and Developmental Biology
Emily T StonehamTheodore C Dumas
April 5, 2021

Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia.

Journal of Clinical Psychopharmacology
John WangDonald C Goff
April 4, 2021
Open Access

IL-33 in Mental Disorders.

Gianluca PandolfoSebastiano Gangemi
April 3, 2021
Open Access

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.

International Journal of Molecular Sciences
Jiyoung Kim
April 1, 2021
Open Access

Maternal immune activation alters adult behavior, intestinal integrity, gut microbiota and the gut inflammation.

Brain and Behavior
Wenqiang LiXi Su
April 1, 2021

Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Xi Rong LiXiang Yang Zhang
March 31, 2021
Open Access

Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Scientific Reports
Tim W RattayDirk Wildgruber
March 31, 2021
Open Access

Klotho-Dependent Role of 1,25(OH)2D3 in the Brain.

Miribane Dërmaku-SopjaniMentor Sopjani

Sign up to follow this feed and discover related papers.

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.


Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Comorbidity In Psychiatry

There is ongoing debate regarding the handling of comorbidity in psychiatric disorders, and determining whether the issue lies with the categorizations of diagnostic conventions or if there is an underlying pathology that links multiple diseases. Understanding how to give the proper diagnosis/diagnoses would allow for optimal management of the patient. Find the latest research on comorbidity in psychiatry here.

Epigenetics & Psychiatry

Psychiatric disorders are known to be multifaceted in their pathophysiology. Because epigenetic changes can be sensitive to the environment, inherited, and reversible, the study of epigenetics in psychiatric disease is a logical way to understand the natural history of the disease as well as to develop therapeutics. Find the latest research on epigenetics and psychiatry here.

Forensic Psychiatry

Forensic psychiatry includes the relationship between psychiatric abnormalities and legal violations and crimes. Discover the latest research on forensic psychiatry here.


Neuropsychiatry is an emerging field at the intersection of neurology and psychiatry, driven by the unprecedented advances in neuroscience. Here are the latest discoveries in neuropsychiatry.

Paranoid Disorders

Paranoid disorders are psychiatric disorders with the suspicion and belief that others are plotting against them, leading to mistrust of others. These symptoms of paranoia can be seen in other psychiatric disorders including dementia and schizophrenia. Here is the latest research on paranoid disorders.

Personality Disorders

Personality disorders are a class of mental disorders characterized by enduring maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from those accepted by the individual's culture. Discover the latest research on personality disorders here.

© 2021 Meta ULC. All rights reserved